These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29064601)

  • 1. Differential involvement of nigral subregions in idiopathic parkinson's disease.
    Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Shin DH; Kim EY
    Hum Brain Mapp; 2018 Jan; 39(1):542-553. PubMed ID: 29064601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
    Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
    Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI.
    Sung YH; Noh Y; Kim EY
    Hum Brain Mapp; 2021 Jun; 42(9):2823-2832. PubMed ID: 33751680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of a high-spatial-resolution voxelwise analysis of neuromelanin-sensitive imaging in early-stage idiopathic Parkinson's disease.
    Seong M; Park S; Sung YH; Kim EY
    BMC Med Imaging; 2023 May; 23(1):64. PubMed ID: 37202720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson's disease.
    Shin DH; Heo H; Song S; Shin NY; Nam Y; Yoo SW; Kim JS; Yoon JH; Lee SH; Sung YH; Kim EY
    Parkinsonism Relat Disord; 2021 Apr; 85():84-90. PubMed ID: 33761389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Nigrosome-1 Sign Identification via Interpretable AI using True Susceptibility Weighted Imaging.
    Wang C; He N; Zhang Y; Li Y; Huang P; Liu Y; Jin Z; Cheng Z; Liu Y; Wang Y; Zhang C; Haacke EM; Chen S; Yan F; Yang G
    J Magn Reson Imaging; 2024 Nov; 60(5):1904-1915. PubMed ID: 38236577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.
    Schwarz ST; Mougin O; Xing Y; Blazejewska A; Bajaj N; Auer DP; Gowland P
    Neuroimage Clin; 2018; 19():683-689. PubMed ID: 29872633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic Segmentation and Quantification of Nigrosome-1 Neuromelanin and Iron in MRI: A Candidate Biomarker for Parkinson's Disease.
    Ariz M; Martínez M; Alvarez I; Fernández-Seara MA; Castellanos G; ; Pastor P; Pastor MA; Ortiz de Solórzano C
    J Magn Reson Imaging; 2024 Aug; 60(2):534-547. PubMed ID: 37915245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical thinning pattern according to differential nigrosome involvement in patients with Parkinson's disease.
    Shin NY; Kim BH; Yun E; Yoon U; Lee JM; Sung YH; Kim EY
    Neuroimage Clin; 2020; 28():102382. PubMed ID: 32828029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Early-Stage Idiopathic Parkinson's Disease Using High-Resolution Quantitative Susceptibility Mapping Combined with Histogram Analysis in the Substantia Nigra at 3 T.
    Kim EY; Sung YH; Shin HG; Noh Y; Nam Y; Lee J
    J Clin Neurol; 2018 Jan; 14(1):90-97. PubMed ID: 29629545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
    He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
    Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced Parkinsonism versus Idiopathic Parkinson Disease: Utility of Nigrosome 1 with 3-T Imaging.
    Sung YH; Noh Y; Lee J; Kim EY
    Radiology; 2016 Jun; 279(3):849-58. PubMed ID: 26690908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
    Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification analysis of 123I-IPT single photon emission computed tomography uptake in the striatum of parkinsonism with the standard magnetic resonance template.
    Juh R; Pae CU; Lee CU; Kim J; Moon D; Suh T; Choe B
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):18-28. PubMed ID: 16472355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of susceptibility-weighted imaging and susceptibility map-weighted imaging for the diagnosis of Parkinsonism with nigral hyperintensity.
    Bae YJ; Song YS; Choi BS; Kim JM; Nam Y; Kim JH
    Eur J Radiol; 2021 Jan; 134():109398. PubMed ID: 33264728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization study.
    Kingsbury AE; Marsden CD; Foster OJ
    Mov Disord; 1999 Mar; 14(2):206-18. PubMed ID: 10091611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.